Literature DB >> 3892009

Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model.

A M Verweij-van Vught, F Namavar, M Sparrius, W A Vel, D M MacLaren.   

Abstract

An animal model is described for quantitative evaluation of pathogenic synergy between Escherichia coli and Bacteroides fragilis in which adjuvants were not required for abscess formation. Two sets of strains of E. coli and B. fragilis isolated from human wound infections were tested. Pathogenic synergy was observed in only one of the two combinations and was dependent on properties of E. coli.

Entities:  

Mesh：

Year:  1985        PMID： 3892009     DOI： 10.1099/00222615-19-3-325

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  6 in total

1.  Synergy in polymicrobial infections in a mouse model of type 2 diabetes.

Authors:  Matthew D Mastropaolo; Nicholas P Evans; Meghan K Byrnes; Ann M Stevens; John L Robertson; Stephen B Melville
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles.

Authors:  Changyoon Baek; MeeRee Han; Junhong Min; Mark R Prausnitz; Jung-Hwan Park; Jung Ho Park
Journal:  J Control Release       Date:  2011-05-07       Impact factor: 9.776

3.  Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.

Authors:  H Hof; A Christen; J Hacker
Journal:  Infection       Date:  1986 Jul-Aug       Impact factor: 3.553

4.  Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.

Authors:  F Namavar; J A Kaan; A M Verweij-van Vught; W A Vel; M Bal; A D Kester; D M MacLaren
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

Review 5.  Pathogenic synergy: mixed intra-abdominal infections.

Authors:  D M MacLaren; F Namavar; A M Verweij-Van Vught; W A Vel; J A Kaan
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

6.  Characterization of a hemoglobin protease secreted by the pathogenic Escherichia coli strain EB1.

Authors:  B R Otto; S J van Dooren; J H Nuijens; J Luirink; B Oudega
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.